Study of COVID-19 DNA Vaccine (AG0301-COVID19)

NCT04463472 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: AG0301-COVID19
BIOLOGICAL: AG0301-COVID19

Sponsor

AnGes, Inc.

Collaborators

[object Object]